Screener
Oruka Therapeutics, Inc. ORKA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$31.82M-51.5% | -$29.58M+64.7% | -$30.28M-5.8% | -$24.57M-10.5% | -$21M-197% | ||
| $43K+169% | $28K+3.7% | $20K+81.8% | $19K+533% | $16K+433% | ||
| $6.97M+42.7% | $4.12M-72.4% | $10.17M+4.1% | $5.08M+561% | $4.88M+5,645% | ||
| -$23.58M-13.0% | -$22.59M+60.9% | -$21.6M+44.6% | -$23.15M-107% | -$20.87M-12,322% | ||
| $73K+462% | $63K-66.7% | $99K-42.1% | $34K— | $13K— | ||
| -$14.44M-134% | -$22.02M+93.3% | -$122.45M-71,508% | $4.86M— | $42.87M— | ||
| $40.6M— | $298K-99.9% | $169.91M-62.2% | —— | —— | ||
| $2.59M-88.2% | -$44.32M-172% | $25.86M-93.7% | -$18.18M-220% | $22M+1,540% | ||
| -$23.65M-13.3% | -$22.66M+61.0% | -$21.7M+44.6% | -$23.18M— | -$20.88M— |
FAQ
- How much cash does Oruka Therapeutics, Inc. generate?
- Oruka Therapeutics, Inc. (ORKA) generated -$90.9M in operating cash flow over the trailing twelve months.
- What is Oruka Therapeutics, Inc.'s free cash flow?
- After $269.0K of capital expenditures, Oruka Therapeutics, Inc.'s free cash flow was -$91.2M over the trailing twelve months, up 23.6% year over year.
- Where does Oruka Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.